Photoreceptor Function in Retinopathy of Prematurity
Photoreceptor Function in Retinopathy of Prematurity
批准号:
7534766
负责人:
ANNE B FULTON
金额:
$56.01万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-03-01 至 2010-11-30
关键词:
1 year oldAgeAmblyopiaAmetropiasAnisometropiaArteriesAttentionBiologyBlood VesselsCaliberChildCross-Sectional StudiesDataDevelopmentDiseaseElectrodesEyeFunctional disorderFutureGrowthHypoxiaImageInfantIntensive CareKnowledgeLeadLengthMeasurementMeasuresMediatingMetabolicModelingNewborn InfantNurseriesOutcomeOxygenPhotoreceptorsProbabilityProceduresProcessRattusRecording of previous eventsRefractive ErrorsResearch PersonnelRetinaRetinalRetinopathy of PrematurityRhodopsinRod Outer SegmentsSamplingSideSkinStimulusTestingTimeUpdateVariantVeinsVisionVisualbasecell motilitycycloplegicdisorder of macula of retinaearly childhoodfovea centralishigh riskinfancyinsightmonocularrelating to nervous systemresearch studyresponseretina blood vessel structureretinal rodsvisual threshold
中文摘要
早产儿活动性视网膜病变(ROP)是对视网膜缺氧的一种反应,发生在
杆状外节快速发育的年龄。研究人员推测,迅速增加的氧气
发育中的杆状细胞的需求促成了引发ROP的缺氧,并作为一种结果
新陈代谢需求得不到满足,视杆功能受损。同时承认“光感受器假说
ROP“不会被直接测试,光感受器的发展和ROP的知识创造了
该项目的框架。在月经后年龄的ROP受试者中完成的研究记录了
受损的棒子。在新项目的目标1中,将在早产儿测量杆状细胞敏感度Srod
在此期间,ROP通常是活动的。这一点很重要,因为在活动中演示了杆的参与
ROP将为ROP管理提供新的视角,其原则将是:满足氧气
光感受器的需求。将对早产儿视网膜血管进行数值分析。Srod和
血管参数将被分析以预测ROP的结局,高危前期的概率
阈值ROP,以及视网膜和视觉功能的后期发展。在健康ROP受试者中,轻度
视力障碍可能是轻微黄斑病变的常见症状,因为这是神经血管改变的残留物
中心凹和中心凹无血流区的发育。在目标2中,将评估中央视网膜功能
(包括ROP婴儿的多焦ERG),并跟踪整个儿童早期。迄今的结果显示
视杆功能障碍与早期屈光不正的关系,但关于视网膜的更多信息仍有待发现
ROP儿童发展为早期屈光不正的比例很大。因此,
Aim 3的实验将更新屈光测量并分析儿童ROP的视网膜机制
以前在婴儿期进行研究的受试者。对于每一组实验,对十字的分析
切片数据将评估视网膜和视觉参数与ROP结果的显著差异。这个
将评估纵向数据随时间的变化以及随ROP结果的变化。该项目将
获得有关基础疾病过程的新知识,有助于理解屈光不正
ROP的发展,并对常见视力缺陷的基础提供了新的见解。此信息
未来可能会改变婴儿期和有ROP病史的儿童ROP的管理。
英文摘要
Active retinopathy of prematurity (ROP), which is known to be a response to retinal hypoxia, occurs at the
age of rapid rod outer segment development. The investigators postulate that rapidly increasing oxygen
demands of the developing rods contribute to the hypoxia that instigates ROP, and, as a consequence of
unmet metabolic needs, rod function is impaired. While acknowledging that the "photoreceptor hypothesis of
ROP" will not be put to direct test, knowledge of the development of the photoreceptors and of ROP creates
a framework for the project. Completed studies in ROP subjects at post-term ages document evidence of
damaged rods. In Aim 1 of the new project, rod cell sensitivity, Srod, will be measured at pre-term ages
during which ROP is typically active. This is important because demonstration of rod involvement in active
ROP will warrant a new perspective on ROP management, the principle of which will be: Satisfy oxygen
needs of photoreceptors. A numeric analysis of preterm retinal blood vessels will be conducted. Srod and
blood vessel parameters will be analyzed for prediction of ROP outcome, the probability of high risk pre-
threshold ROP, and post-term development of retinal and visual function. In healthy ROP subjects, mild
acuity deficits may be the common sign of a subtle maculopathy as residua of altered neural-vascular
development of fovea and foveal avascular zone. In Aim 2, central retinal function will be evaluated
(including multifocal ERG in ROP infants) and tracked through early childhood. Results to date demonstrate
an association of rod dysfunction and early ametropia, but more remains to be discovered about retinal
mechanisms in that substantial proportion of ROP children who develop early ametropia. Accordingly, the
experiments of Aim 3 will update refractive measurements and analyze retinal mechanisms in child ROP
subjects who were previously studied in infancy. For each set of experiments, the analyses of the cross
sectional data will evaluate the retinal and visual parameters for significant variation with ROP outcome. The
longitudinal data will be evaluated for change over time and for variation with ROP outcome. The project will
obtain new knowledge about the fundamental disease process, contribute to the understanding of refractive
development in ROP, and provide new insights into the basis of common acuity deficits. This information
may, in the future, change management of ROP in infancy and in children with a history of ROP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Adaptive Optics Imager for Study of Pediatric Retinal Disorders
-
批准号:7595302
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2009
-
负责人:ANNE B FULTON
-
依托单位:
A SYSTEM FOR STUDY OF PEDIATRIC VISUAL PATHWAYS: EYE
-
批准号:6973582
-
项目类别:
-
资助金额:$11.29万
-
财政年份:2004
-
负责人:ANNE B FULTON
-
依托单位:
A SYSTEM FOR STUDY OF PEDIATRIC VISUAL PATHWAYS: NEUROSCIENCE
-
批准号:6973583
-
项目类别:
-
资助金额:$3.76万
-
财政年份:2004
-
负责人:ANNE B FULTON
-
依托单位:
A System for Study of Pediatric Visual Pathways
-
批准号:6731462
-
项目类别:
-
资助金额:$15.06万
-
财政年份:2004
-
负责人:ANNE B FULTON
-
依托单位:
Retcam 120 Wide Field Digital Imaging System
-
批准号:6440432
-
项目类别:
-
资助金额:$10.25万
-
财政年份:2002
-
负责人:ANNE B FULTON
-
依托单位:
GENOTYPE & PHENOTYPE IN LEBER CONGENITAL AMAUROSIS & RELATED RETINAL DISORDERS
-
批准号:6568561
-
项目类别:
-
资助金额:$2.88万
-
财政年份:2001
-
负责人:ANNE B FULTON
-
依托单位:
GENOTYPE & PHENOTYPE IN LEBER CONGENITAL AMAUROSIS & RELATED RETINAL DISORDERS
-
批准号:6441967
-
项目类别:
-
资助金额:$2.88万
-
财政年份:2000
-
负责人:ANNE B FULTON
-
依托单位:
GENOTYPE & PHENOTYPE IN LEBER CONGENITAL AMAUROSIS & RELATED RETINAL DISORDERS
-
批准号:6485566
-
项目类别:
-
资助金额:$2.88万
-
财政年份:2000
-
负责人:ANNE B FULTON
-
依托单位:
GENOTYPE & PHENOTYPE IN LEBER CONGENITAL AMAUROSIS & RELATED RETINAL DISORDERS
-
批准号:6308974
-
项目类别:
-
资助金额:$2.88万
-
财政年份:1999
-
负责人:ANNE B FULTON
-
依托单位:
GENOTYPE & PHENOTYPE IN LEBER CONGENITAL AMAUROSIS & RELATED RETINAL DISORDERS
-
批准号:6265648
-
项目类别:
-
资助金额:$0.07万
-
财政年份:1998
-
负责人:ANNE B FULTON
-
依托单位:
PHOTORECEPTOR FUNCTION IN RETINOPATHY OF PREMATURITY
-
批准号:6518524
-
项目类别:
-
资助金额:$35.55万
-
财政年份:1994
-
负责人:ANNE B FULTON
-
依托单位:
DEVELOPMENT OF PHOTORECEPTOR FUNCTION
-
批准号:2882906
-
项目类别:
-
资助金额:$20.93万
-
财政年份:1994
-
负责人:ANNE B FULTON
-
依托单位:
PHOTORECEPTOR FUNCTION IN RETINOPATHY OF PREMATURITY
-
批准号:6635635
-
项目类别:
-
资助金额:$35.55万
-
财政年份:1994
-
负责人:ANNE B FULTON
-
依托单位:
Photoreceptor Function in ROP
-
批准号:9445683
-
项目类别:
-
资助金额:$62.95万
-
财政年份:1994
-
负责人:ANNE B FULTON
-
依托单位:
Photoreceptor Function in Retinopathy of Prematurity
-
批准号:7030403
-
项目类别:
-
资助金额:$53.99万
-
财政年份:1994
-
负责人:ANNE B FULTON
-
依托单位:
PHOTORECEPTOR FUNCTION IN RETINOPATHY OF PREMATURITY
-
批准号:6266862
-
项目类别:
-
资助金额:$35.55万
-
财政年份:1994
-
负责人:ANNE B FULTON
-
依托单位:
Photoreceptor Function in Retinopathy of Prematurity
-
批准号:8245704
-
项目类别:
-
资助金额:$58.15万
-
财政年份:1994
-
负责人:ANNE B FULTON
-
依托单位:
Photoreceptor Function in ROP
-
批准号:10756658
-
项目类别:
-
资助金额:$32.57万
-
财政年份:1994
-
负责人:ANNE B FULTON
-
依托单位:
DEVELOPMENT OF ROD FUNCTION
-
批准号:2164587
-
项目类别:
-
资助金额:$17.52万
-
财政年份:1994
-
负责人:ANNE B FULTON
-
依托单位:
Photoreceptor Function in Retinopathy of Prematurity
-
批准号:7344675
-
项目类别:
-
资助金额:$53.92万
-
财政年份:1994
-
负责人:ANNE B FULTON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: